-+ 0.00%
-+ 0.00%
-+ 0.00%

LYNOZYFIC™ (LINVOSELTAMAB) MONOTHERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) SHOWS IMPRESSIVE RESPONSES, SUPPORTING RATIONALE AS A POTENTIAL FOUNDATION IN FRONTLINE TREATMENT

Reuters·12/07/2025 21:31:25

Please log in to view news